Sign in or Register

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Antibody Array

Antibody Array

Antibody array, also known as antibody microarray, is a high-throughput technique that is able to detect multiple proteins simultaneously with minimal sample volume requirements. Compared with other traditional, single analyte methods of protein analysis, antibody array has demonstrated a number of advantages such as small sample volume and antibody concentration requirements, higher format versatility, reproducibility. These advantages support the increasing use of antibody arrays in clinical applications including disease marker discovery for diagnosis, prognosis, and drug response, characterization of signaling and protein pathways, and modifications associated with disease development and progression. Now, antibody arrays have become more standardized and user-friendly experimental procedures.

Fig.2 Designing and developing antibody arrays (Wingren et al)

Creative Biolabs has developed antibody array technology platform and various antibody array products have been provided. If you have special needs, Creative Biolabs also provides antibody array customization services for your exact applications.

Here are what we have and can be provided: